Salvage surgery for advanced non‐small cell lung cancer after targeted therapy: A case series

BACKGROUND: Tumor recurrence or residual tumor after targeted therapy is common in patients with advanced non‐small cell lung cancer (NSCLC). There is a lack of high‐level evidence on which type of treatment should be employed for these patients and the role of salvage surgery has not been well repo...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Weian, Di, Shouyin, Liu, Junqiang, Fan, Boshi, Zhao, Jiahua, Zhou, Shaohua, Chen, Siyu, Dong, Hai, Yue, Caiying, Gong, Taiqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113042/
https://www.ncbi.nlm.nih.gov/pubmed/32107870
http://dx.doi.org/10.1111/1759-7714.13366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113042/
https://www.ncbi.nlm.nih.gov/pubmed/32107870
http://dx.doi.org/10.1111/1759-7714.13366

Ejemplares similares